For discerning immune cell signaling states associated with disease escalation in COVID-19 based on prospective patient samples in order to identify therapeutic targets to modulate inflammation in COVID-19 patients.
- Funded by Emergent Ventures Fast Grants
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
N/AFunder
Emergent Ventures Fast GrantsPrincipal Investigator
Dr. Matthew SpitzerResearch Location
United States of AmericaLead Research Institution
University of California-San FranciscoResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnosticsResearch Subcategory
ImmunitySpecial Interest Tags
N/AStudy Type
Non-ClinicalClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified
Abstract
For discerning immune cell signaling states associated with disease escalation in COVID-19 based on prospective patient samples in order to identify therapeutic targets to modulate inflammation in COVID-19 patients.